The role of Ranolazine alone or in combination with a Class III anti-arrhythmic drug for DC cardioversion for persistent AF

7 April 2024 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session on atrial fibrillation and supraventricular tachycardia Rhythm Control, Cardioversion EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)